Form D · Biotechnology
Biorez, Inc.
New Haven, CT · CIK 0001431625
Offering snapshot reported Jun 25, 2021 · SEC filing
- Reported sold
- $3.9M Offering amount: $5M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2021 | Initial | $3,900,000 | No comparison | Not reported | SEC filing |
| Sep 16, 2020 | Amendment | $3,500,000 | $1,693,000vs Jul 11, 2019 | 33 | SEC filing |
| Jul 11, 2019 | Initial | $1,807,000 | No comparison | 17 | SEC filing |
| Mar 14, 2018 | Initial | $1,447,000 | No comparison | 15 | SEC filing |
| Dec 5, 2016 | Initial | $1,485,578 | No comparison | 6 | SEC filing |
| Nov 4, 2015 | Amendment | $7,668,852 | $50,000vs Nov 7, 2014 | 19 | SEC filing |
| Nov 7, 2014 | Amendment | $7,618,852 | $2,916,326vs Dec 5, 2013 | 18 | SEC filing |
| Dec 5, 2013 | Initial | $4,702,526 | No comparison | 14 | SEC filing |
| Mar 11, 2013 | Amendment | $4,210,000 | $2,960,000vs Sep 29, 2011 | 15 | SEC filing |
| Sep 29, 2011 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
| Jul 7, 2010 | Amendment | $2,804,767 | $1,750,000vs Jul 20, 2009 | 13 | SEC filing |
| Jul 20, 2009 | Initial | $1,054,767 | No comparison | 3 | SEC filing |
| Sep 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-404260
Source: Form D, filed Jun 25, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael B Aronson | Director |
| Jeffery A. Baird | Executive |
| Konstantine Drakonakis | Director |
| Richard Emmitt | Director |
| Charles Hart | Director |
| Paul Hermes | Director |
| Robert S Langer | Director |
| Cato Laurencin | Promoter |
| Sacha Levy | Director |
| Dane Miller | Director |
| Nicholas Pachuda | Director |
| Joseph W Reilly | Director, Executive, Promoter |
| Kevin A Rocco | Director, Executive |
| Levy Sacha | Director |
| Russell E Tweeddale | Director |
| Daniel Wagner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
470 James Street #14
New Haven, CT, 06513
New Haven, CT, 06513